Effectiveness of homologous/heterologous booster COVID-19 vaccination schedules against severe illness in general population and clinical subgroups in three European countries

Fabio Riefolo, Belén Castillo-Cano, Mar Martín-Pérez, Davide Messina, Roel Elbers, Dorieke Brink-Kwakkel, Felipe Villalobos, Ylenia Ingrasciotta, Patricia Garcia-Poza, Karin Swart-Polinder, Patrick Souverein, Luis Carlos Saiz, Carlo Alberto Bissacco, Leire Leache, Michele Tari, Salvatore Crisafulli, Lamiae Grimaldi, Tiago Vaz, Rosa Gini, Olaf KlungelElisa Martín-Merino*

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Fingerprint

Dive into the research topics of 'Effectiveness of homologous/heterologous booster COVID-19 vaccination schedules against severe illness in general population and clinical subgroups in three European countries'. Together they form a unique fingerprint.

Keyphrases

Medicine and Dentistry

Immunology and Microbiology

Pharmacology, Toxicology and Pharmaceutical Science